404 related articles for article (PubMed ID: 20937383)
1. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
Perez SE; He B; Muhammad N; Oh KJ; Fahnestock M; Ikonomovic MD; Mufson EJ
Neurobiol Dis; 2011 Feb; 41(2):338-52. PubMed ID: 20937383
[TBL] [Abstract][Full Text] [Related]
2. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes.
Hernandez D; Sugaya K; Qu T; McGowan E; Duff K; McKinney M
Neuroreport; 2001 May; 12(7):1377-84. PubMed ID: 11388415
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
4. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
[TBL] [Abstract][Full Text] [Related]
6. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C
Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619
[TBL] [Abstract][Full Text] [Related]
8. Mouse models of Alzheimer's disease: insight into treatment.
German DC; Eisch AJ
Rev Neurosci; 2004; 15(5):353-69. PubMed ID: 15575491
[TBL] [Abstract][Full Text] [Related]
9. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
10. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
11. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
12. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
[TBL] [Abstract][Full Text] [Related]
13. Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice.
Yan XX; Cai Y; Shelton J; Deng SH; Luo XG; Oddo S; Laferla FM; Cai H; Rose GM; Patrylo PR
PLoS One; 2012; 7(11):e48782. PubMed ID: 23155407
[TBL] [Abstract][Full Text] [Related]
14. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
[TBL] [Abstract][Full Text] [Related]
15. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
17. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice.
Jagadeesan N; Roules GC; Chandrashekar DV; Yang J; Kolluru S; Sumbria RK
J Transl Med; 2024 Mar; 22(1):291. PubMed ID: 38500108
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta expression in retrosplenial cortex of triple transgenic mice: relationship to cholinergic axonal afferents from medial septum.
Robertson RT; Baratta J; Yu J; LaFerla FM
Neuroscience; 2009 Dec; 164(3):1334-46. PubMed ID: 19772895
[TBL] [Abstract][Full Text] [Related]
19. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.
Belfiore R; Rodin A; Ferreira E; Velazquez R; Branca C; Caccamo A; Oddo S
Aging Cell; 2019 Feb; 18(1):e12873. PubMed ID: 30488653
[TBL] [Abstract][Full Text] [Related]
20. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
